Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123927722 | 12392772 | 2 | F | 201504 | 20160829 | 20160523 | 20160902 | PER | US-JAZZ-2015-US-014668 | JAZZ | 37.84 | YR | F | Y | 45.81000 | KG | 20160902 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123927722 | 12392772 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 123927722 | 12392772 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 123927722 | 12392772 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 123927722 | 12392772 | 4 | C | CELEBREX | CELECOXIB | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 123927722 | 12392772 | 5 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 123927722 | 12392772 | 6 | C | PROVIGIL | MODAFINIL | 1 | UNK | U | 0 | TABLET | |||||||||
| 123927722 | 12392772 | 7 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 123927722 | 12392772 | 8 | C | DIAZEPAM. | DIAZEPAM | 1 | UNK | U | 0 | TABLET | |||||||||
| 123927722 | 12392772 | 9 | C | MOTRIN IB | IBUPROFEN | 1 | UNK | U | 0 | ||||||||||
| 123927722 | 12392772 | 10 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 123927722 | 12392772 | 11 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 123927722 | 12392772 | 12 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123927722 | 12392772 | 1 | Narcolepsy |
| 123927722 | 12392772 | 2 | Somnolence |
| 123927722 | 12392772 | 4 | Product used for unknown indication |
| 123927722 | 12392772 | 5 | Product used for unknown indication |
| 123927722 | 12392772 | 6 | Product used for unknown indication |
| 123927722 | 12392772 | 7 | Product used for unknown indication |
| 123927722 | 12392772 | 8 | Product used for unknown indication |
| 123927722 | 12392772 | 9 | Product used for unknown indication |
| 123927722 | 12392772 | 10 | Product used for unknown indication |
| 123927722 | 12392772 | 11 | Product used for unknown indication |
| 123927722 | 12392772 | 12 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123927722 | 12392772 | Activities of daily living impaired | |
| 123927722 | 12392772 | Anxiety | |
| 123927722 | 12392772 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123927722 | 12392772 | 1 | 201503 | 201503 | 0 | |
| 123927722 | 12392772 | 2 | 2015 | 2015 | 0 | |
| 123927722 | 12392772 | 3 | 201506 | 0 | ||
| 123927722 | 12392772 | 4 | 20150709 | 0 | ||
| 123927722 | 12392772 | 5 | 20141101 | 0 | ||
| 123927722 | 12392772 | 6 | 20140901 | 20150923 | 0 | |
| 123927722 | 12392772 | 7 | 20140301 | 0 | ||
| 123927722 | 12392772 | 8 | 20050101 | 0 | ||
| 123927722 | 12392772 | 9 | 20000101 | 0 | ||
| 123927722 | 12392772 | 10 | 20000101 | 0 | ||
| 123927722 | 12392772 | 11 | 20141101 | 20150709 | 0 | |
| 123927722 | 12392772 | 12 | 20050101 | 20150302 | 0 |